POWDER INHALER

Abstract: An inhaler device (20) for administration of a dry powder (66) to a patient includes a package (22) containing a dose of the dry powder and a magnetic field generator (36, 38), which produces a magnetic field in a vicinity of the package. The magnetic field causes motion of particles of the powder so as to deaggregate the powder in the package, whereby the powder is inhaled by the patient. Preferably, the package includes walls (23, 25) made of a flexible material, which vibrate under the influence of the magnetic field so as to impart the motion to the particles.

Description: POWDER INHALER FIELD OF THE INVENTION The present invention relates generally to drug delivery devices, and specifically to devices and methods for delivery of drugs by inhalation BACKGROUND OF THE INVENTION Drug delivery by inhalation is well known in the treatment of respiratory disorders, such as asthma Inhalation has also found use in delivery of systemic drugs through the lungs, wherein the drugs are absorbed directly into the blood stream without having to pass through (and be broken down by) the digestive tract Ultra-fine, dry powders, also known as micro- and nano-powders, are the subject of increasing interest in pharmaceutical manufacturing, because they provide a solution to many of the shortcomings of blended drugs Active drug ingredients are produced, packaged and administered to the patient as pure, dry powders, without blending them with solvents or other agents Elimination of the blending steps simplifies the manufacturing process, reduces development and manufacturing costs, makes dosage more accurate, and extends the drug's shelf life Dry powder inhalers are known in the art, for delivery of dry powder medications to the lungs For optimal penetration and absorption in the lungs, the powder particles should be particularly fine - on the order of 4 μm in size, or less The drawback of such ultra-fine, dry powders is that they are difficult to handle, tending to clump and stick in storage and to scatter when disturbed by even slight air movements These handling problems must be overcome if dry powder drugs are to be used efficiently and safely, and special methods must be used for accurate dose processing and administration PCT patent publications WO 97/47346 and WO 97/47347, which are incorporated herein by reference, describe inhaler apparatus for use with fine powders A dry powder inside the inhaler apparatus initially adheres to a substrate surface therein When a patient using the apparatus inhales, an electrostatic field is triggered inside the inhaler The field causes the powder to be lifted from the surface and drawn into the patient's mouth To be handled in this manner, the powder must be pre-charged For practical field intensities (in a hand-held device that is inserted in the patient's mouth), the amount of powder that can be delivered is limited Furthermore, application of the field must be precisely timed relative to the patient's inhalation to avoid scattering the powder, and the air flow trigger required for this purpose is costly and complex. MicroDose Technologies Inc., of New Jersey, offers a dry powder inhaler based on the general principles described in the above-mentioned PCT publications. In addition to the used of a timed electrostatic field, the MicroDose inhaler uses a piezoelectric vibrator, brought into contact with a blister pack containing the powder, to deaggregate the particles. The mechanical interface for transferring the vibrations to the powder in the pack is inefficient and further increases the cost and complexity of the inhaler. SUMMARY OF THE INVENTION It is an object of the present invention to provide improved devices and methods for delivery of dry powders to a patient by inhalation. It is a further object of some aspects of the present invention to provide a dry powder inhaler device that deaggregates the powder without the need for a direct mechanical interface to transfer vibrations to a package containing the powder. It is yet a further object of some aspects of the present invention to provide a dry powder inhaler device from which the powder is released during inhalation by a patient using of the device, without the need for an air flow sensor or other means of active synchronization with the patient's respiration. It is still a further object of some aspects of the present invention to provide a multi-dose dry powder inhaler device, and particularly such a device that allows convenient tracking of dosage and patient compliance. In preferred embodiments of the present invention, a dry powder for delivery to a patient by inhalation is contained in a package having an opening through which the powder flows when the patient inhales. In some of these preferred embodiments, the powder is deaggregated and mobilized by application of a magnetic field. Preferably, the field interacts with the package, engendering rapid motion thereof, which deaggregates the powder. According to an other aspect of the present invention, an electrostatic valve screen is created by means of an alternating electrostatic field in a vicinity of the opening, so as to trap particles of the powder and prevent their escape from the package except during inhalation. In some preferred embodiments of the present invention, the alternating electrostatic field is applied using electrodes at either side of the opening. Only when air is made to flow through the opening at a rate above a given threshold, which is generally determined by the voltage applied between the electrodes, can the powder flow out through the electrostatic valve screen. The voltage is preferably set so that the flow rate passes the threshold when the patient inhales, whereby the powder is drawn out of the package and into the patient's lungs. In some preferred embodiments of the present invention, the package comprises flexible side walls, which are made to vibrate by application of the magnetic field. The vibration of the walls deaggregates the powder in the package and generates air flow which suspends the powder in the air inside the package. In some of these preferred embodiments, the side walls of the package are coupled to electrical wiring, preferably to coils in the form of electrical conductors applied to a surface of the walls in the manner of a flexible printed circuit. One or more permanent magnets apply a fixed magnetic field to the package. The coils on the walls of the package are driven by an alternating electrical current, generating a field that interacts with the fixed magnetic field and thus causes the walls to vibrate. Preferably, the walls comprise an array of coils, which are driven cooperatively to control the mode of vibration of the walls and thus regulate the air flow inside the package. Preferably, the external magnetic field has a component in a direction perpendicular to a coil axis, in the plane of the coils, causing the walls to vibrate along the axis. Alternatively or additionally, the magnetic field has a component perpendicular to the plane of the coils, causing lateral vibrations. In other preferred embodiments, the side walls of the package comprise a magnetic material, which is preferably coated on a surface of the walls. The magnetic field is applied by driving an electromagnet outside the package with an alternating current, which thus causes the walls to vibrate. Preferably, the flexible side walls are made to vibrate at a resonant vibration frequency thereof, in order to maximize the vibrational energy. Most preferably, a frequency of the alternating current applied to the coils on the walls or to the electromagnet is set so as to engender the resonant vibration. In a preferred embodiment, the frequency of the alternating current is swept through a range of frequencies, preferably including the resonant frequency, and is then set at the frequency that maximizes the effectiveness of deaggregation, which is typically the frequency that maximizes the wall vibration. For this purpose, a vibration sensor is preferably coupled to the wall and provides feedback for use in controlling the frequency of the alternating current. In another preferred embodiment, the vibration sensor is coupled in a positive feedback loop to a driver that provides the alternating current, causing the loop to spontaneously oscillate at or near the resonant frequency. In still other preferred embodiments of the present invention, the powder particles comprise an electrically- or magnetically-active component, preferably in the form of a coating on or a compound in the particles. In some of these preferred embodiments, in which the particles are magnetically active, the application of the magnetic field deaggregates the particles without the necessity of vibrating the walls of the package. Preferably, the field is driven to alternate at or near a resonant motion frequency of the particles. In other preferred embodiments, the electrically- active component enables charging of the particles with a low work function, by contact of the particles with a conductive area of the walls. The charged particles then interact with the electrostatic screen with enhanced efficiency. In some preferred embodiments of the present invention, a powder inhaler device, operating as described hereinabove, comprises a disposable package, which is introduced into and actuated by a reusable control and power unit. Preferably, the package is a part of a multi-dose cartridge, which most preferably comprises multiple packets of the dry powder, which are actuated in succession. In a preferred embodiment, the control and power unit includes a dose counter, as well as an appropriate user interface, which informs and reminds a patient as to dosage to be administered. The dose counter can also be used to record patient dosage and compliance data to be read out subsequently by medical caregivers. In yet other preferred embodiments of the present invention, the powder is deaggregated and mobilized by the action of a mechanical impactor, which applies mechanical energy to the container periodically so as to induce resonant oscillatory motion of the container. Preferably, the impactor comprises an eccentric rotating element, such as a cam. Alternatively, the impactor may comprise an electromagnetic or piezoelectric oscillating element. The impactor is positioned so as to contact the container only at or near one extreme of the container's oscillation. In this position, the impactor necessarily strikes and imparts energy to the container only in synchronization with the oscillation, even if the motion of the impactor itself is not synchronized precisely with the resonance of the container. In some of these preferred embodiments, the container is configured to oscillate at two different levels of vibrational amplitude: a low level to deaggregate the powder, and a high level to aerosolize the powder. The high-level vibration is induced in order to mobilize the powder when the user of the device inhales. Preferably, the device is configured so that when the user inhales through the device, air pressure changes induced in the device cause the vibrational amplitude to increase, most preferably by means of an increase in the driving force exerted by the impactor on the container. There is therefore provided, in accordance with a preferred embodiment of the present invention, an inhaler device for administration of a dry powder to a patient, including: a package containing a dose of the dry powder; and a magnetic field generator, which produces a magnetic field in a vicinity of the package, causing motion of particles of the powder so as to deaggregate the powder in the package, whereby the powder is inhaled by the patient. Preferably, the package includes walls made of a flexible material, which vibrate under the influence of the magnetic field so as to impart the motion to the particles. Further preferably, the package includes electrical wiring coupled to at least one of the walls and a control unit which drives a time-varying current through the wiring, causing the walls to vibrate due to interaction of the current with the magnetic field. Most preferably, the wiring includes a circuit trace printed on at le::st one of the walls, which forms a plurality of coils. In a preferred embodiment, the control unit drives the plurality of coils at respective relative phases so as to induce a desired mode of vibration of the at least one of the walls. Alternatively, the walls include a magnetic material, and the field generator includes an electromagnet, which produces a time-varying magnetic field, causing the walls to vibrate due to interaction of the magnetic material with the magnetic field. Preferably, the magnetic material includes a coating on the one or more of the walls. In a preferred embodiment, the walls made of the flexible material include opposing side walls of the package, which vibrate in a controlled mutual phase relationship. Preferably, the opposing side walls are driven to vibrate in phase or alternatively, in mutually opposite phases so as to pump the powder out of the package. Preferably, the walls are driven to vibrate at a frequency approximately equal to a resonant vibration frequency thereof. In a preferred embodiment, the device includes a driver circuit, which provides an alternating current of adjustable frequency to drive the vibration of the walls, and a vibration transducer coupled to one of the walls, which transducer provides feedback to the driver circuit, so that the frequency of the alternating current is adjusted such that the walls vibrate at approximately the resonant vibration frequency. Preferably, the driver circuit and transducer are arranged in a self-oscillating positive feedback loop. In another preferred embodiment, the device includes a vibration sensor, which generates signals responsive to vibration of the walls, and a control unit, which receives the signals from the vibration sensor and, responsive thereto, controls the inhaler device so as to regulate an energy of vibration of the walls. Preferably, the control unit provides an alternating current of adjustable frequency to drive the vibration of the walls, and adjusts the frequency of the alternating current in order to maximize the energy of vibration. In a preferred embodiment, the powder includes magnetized particles, and the field generator produces a time-varying magnetic field which interacts with magnetic fields of the particles, causing the particles to move. Preferably, a frequency of the time-varying magnetic field is adjusted so that the particles oscillate at approximately a resonant frequency thereof. In still another preferred embodiment, the package includes a multi-dose cartridge, such that multiple doses of the dry powder are administered to the patient in succession, and the device includes a dose counter which tracks the administration of the doses. There is further provided, in accordance with a preferred embodiment of the present invention, an inhaler device for administration of a dry powder to a patient, including: a package containing a dose of the dry powder and having an opening through which the powder exits the package and is inhaled by the patient; and an electrostatic valve screen, which traps the powder inside the package by generating a time-varying electrostatic field across the opening. Preferably, the valve screen includes a pair of electrodes positioned on opposing sides of the opening. Further preferably, the electrostatic valve screen allows the powder to pass through the opening when a rate of air flow through the opening exceeds a predetermined threshold, wherein the threshold is chosen such that inhalation by the patient generates an air flow through the opening in excess of the threshold. Preferably, the electrostatic field causes particles of the powder to oscillate in a vicinity of the opening. There is also provided, in accordance with a preferred embodiment of the present invention, a method for deaggregation of a dry powder for administration to a patient, including applying a magnetic field so as to cause motion of particles of the powder, whereby the powder is inhaled by the patient. Preferably, the powder is contained in a package having walls made of a flexible material, and applying the magnetic field includes magnetically inducing vibration of the walls so as to impart the motion to the particles. Further preferably, inducing the vibration includes driving a time-varying current in wiring coupled to at least one of the walls, which current interacts with the magnetic field to induce the vibration of the walls. In a preferred embodiment, driving the current includes driving current in different portions of the wiring at respective, relative phases so as to induce a desired mode of vibration of the walls. Alternatively, inducing the vibration includes applying a time-varying magnetic field, which interacts with magnetic material in the walls to induce the vibration. In a preferred embodiment, inducing the vibration includes controlling relative phases of vibration of different ones of the walls. In a further preferred embodiment, inducing the vibration includes driving the vibration at approximately a resonant vibration frequency of the walls. Preferably, inducing the vibration includes sensing vibration of one of the walls and adjusting a frequency of the vibration responsive to the sensing. In still another preferred embodiment, the method includes magnetizing the particles, wherein applying the magnetic field includes applying a time-varying magnetic field which interacts with magnetic fields of the particles, causing the particles to move. There is additionally provided, in accordance with a preferred embodiment of the present invention, a method for administration of a dry powder to a patient, including: providing the dry powder in a package having an opening through which the powder exits the package and is inhaled by the patient; and generating a time-varying electrostatic field across the opening so as to trap the powder inside the package until the patient inhales. Preferably, generating the field includes adjusting the strength of the field so as to allow the powder to pass through the opening only when a rate of air flow through the opening exceeds a predetermined threshold, wherein the threshold is chosen such that inhalation by the patient generates an air flow through the opening in excess of the threshold. Further preferably, generating the electrostatic field causes particles of the powder to oscillate in a vicinity of the opening. There is further provided, in accordance with a preferred embodiment of the present invention, an inhaler device for administration of a dry powder to a patient, including: a container assembly, containing a dose of the dry powder and adapted to oscillate over a predetermined oscillation path between first and second extremes; and an impactor, configured to drive the container assembly to oscillate by contacting the container assembly periodically in a vicinity of the first extreme of the oscillation path, but not in a vicinity of the second extreme, so as to deaggregate the dry powder for inhalation by the patient. Preferably, the container assembly is adapted to oscillate at a resonant frequency of the assembly, so that the impactor contacts the container periodically at the resonant frequency. Further preferably, the device includes an energy source, which is coupled to drive the impactor into motion at a frequency substantially greater than the resonant frequency, wherein the motion of the impactor causes it to contact the container assembly. Preferably, the impactor includes an eccentric rotating element. In a preferred embodiment, the container assembly is configured so that responsive to a flow of air over the assembly, an amplitude of oscillation of the assembly increases. Preferably, the flow of air is induced by the patient's inhalation. There is moreover provided, in accordance with a preferred embodiment of the present invention, an inhaler device for administration of a dry powder to a patient, including: a housing, containing the powder and having an outlet adapted for the patient to inhale the powder therethrough and an inlet through which air is drawn into the housing when the patient inhales; and a deaggregation assembly inside the housing, which is adapted to apply a vibration to the powder so as to deaggregate the powder for inhalation by the patient, such that an amplitude of the vibration is increased when the patient inhales. Preferably, the amplitude of the vibration is increased responsive to the air flowing through the housing when the patient inhales, wherein the air flowing through the housing applies a force to the deaggregation assembly, causing the amplitude of the vibration to increase. Further preferably, before the patient inhales, the amplitude of the vibration of the deaggregation assembly is not sufficient to mobilize the powder substantially, so that the powder remains inside the housing, whereas when the patient inhales, the amplitude of the vibration is increased sufficiently to aerosolize the powder Most preferably, the amplitude of the vibration of the deaggregation assembly is increased to a greater degree in response to a greater strength of inhalation by the patient There is furthermore provided, in accordance with a preferred embodiment of the present invention, a method for administration of a dry powder to a patient, including providing a dose of the dry powder in a container assembly, which is adapted to oscillate over a predetermined oscillation path between first and second extremes, and driving the container assembly to oscillate by striking the container assembly periodically in a vicinity of the first extreme of the oscillation path, but not in a vicinity of the second extreme, so as to deaggregate the dry powder for inhalation by the patient There is moreover provided, in accordance with a preferred embodiment of the present invention, a method for administration of a dry powder to a patient by inhalation, including applying a vibration to the powder at an initial vibration amplitude so as to deaggregate the powder pπor to the inhalation by the patient, and increasing the amplitude of the vibration duπng the inhalation by the patient so as to aerosolize the powder The present invention will be more fully understood from the following detailed descπption of the preferred embodiments thereof, taken together with the drawings in which BRIEF DESCRIPTION OF THE DRAWINGS Fig 1 is a schematic, partly cutaway, pictoπal illustration of an inhaler device, in accordance with a preferred embodiment of the present invention, Fig 2 is a schematic, sectional illustration showing details of a powder package within the inhaler of Fig 1, in accordance with a preferred embodiment of the present invention, Figs 3A, 3B and 4 are schematic illustrations showing operating modes of the package of Fig 2, in accordance with preferred embodiments of the present invention, Fig 5 is a schematic illustration showing details of an inhaler device, in accordance with another preferred embodiment of the present invention, Fig 6A is a schematic, sectional illustration of a particle of a dry powder for delivery to a patient by inhalation, in accordance with a preferred embodiment of the present invention, Fig. 6B is a schematic illustration showing details of an inhaler device for delivery of the powder of Fig. 6 A, in accordance with a preferred embodiment of the present invention; Fig. 7 is a schematic, pictorial illustration of a multi-dose powder dispenser cartridge, in accordance with a preferred embodiment of the present invention; Fig. 8 is a block diagram that schematically illustrates dose counting circuitry used in an inhaler device, in accordance with a preferred embodiment of the present invention; Fig. 9 is a flow chart that schematically illustrates a method for tracking dosage of a medication administered by inhalation, in accordance with a preferred embodiment of the present invention; Fig. 10 is a block diagram that schematically illustrates frequency control circuitry used in driving an inhaler device, in accordance with a preferred embodiment of the present invention; Fig. 11 is a block diagram that schematically illustrates frequency control circuitry used in driving an inhaler device, in accordance with another preferred embodiment of the present invention; Fig. 12 is a schematic, sectional illustration showing details of a powder package, in accordance with another preferred embodiment of the present invention; Fig. 13 is a schematic, sectional view of an inhaler device, in accordance with still another preferred embodiment of the present invention; and Fig. 14 is a schematic end view of an impactor for use in the device of Fig. 13, in accordance with a preferred embodiment of the present invention. DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS Reference is now made to Figs. 1 and 2, which schematically illustrate an inhaler device 20, in accordance with a preferred embodiment of the present invention. Fig. 1 is a schematic, partly cutaway, pictorial view, and Fig. 2 is a sectional detail view. Device 20 comprises a powder package 22, preferably in the form of a disposable, replaceable cartridge, which is inserted into a device housing 24. Package 22 comprises side walls 23 and 25, which enclose a volume 26 in which a medication in the form of a dry powder 66 is contained. The side walls preferably comprise a flexible plastic material, such as Mylar, on which electrical conductors are printed, in the manner of a printed circuit, as is known in the art. The electrical conductors form one or more coils or current loops on each of the side walls. In the embodiment of Figs. 1 and 2, coils 28, 30, 32 and 34 are printed on wall 23, and coils 58, 60, 62 and 64 are pπnted on wall 25 Different numbers of coils or loops, as well as coils and loops of different shapes and forms, may similarly be used Permanent magnets 36 and 38, or alternatively electromagnets or magnetic materials of other types, are placed adjacent to package 22 and produce a generally static magnetic field in and around the package More preferably the poles of the magnets are configured to create a magnetic field component perpendicular to the axes of the coils, I e , in the plane of the walls In a preferred embodiment, the poles are configured as a North-North pair, with the coils in the gap between the poles A control umt 40, powered by a battery 42, dπves an alternating current through the coils, which interacts with the magnetic fields of magnets 36 and 38 so as to induce vibrations in walls 23 and 25, as descπbed further hereinbelow Preferablv, the frequency of the alternating current is adjusted so that the walls are dπven to vibrate at a dominant resonant vibrational frequency of the walls, as further descπbed hereinbelow The vibrations of walls 23 and 25 deaggregate powder 66 and cause air flows m the package that suspend the powder in volume 26 The powder can then pass out of the package through a first opening 41 therein and through an exit port 56 of device 20, when a patient places the port in his or her mouth and inhales For this purpose, device 20 also has an air inlet 54, and package 22 has a second opemng 43 opposite the first one Optionally, control unit 40 tπggers the vibrations responsive to a signal from a flow sensor (not shown), so as to synchronize the deaggregation with inhalation by the patient Optionally, device 20 uses an electrostatic valve screen to prevent escape of particles of powder 66 through openings 41 and 43 except when the patient inhales The screen takes advantage of the fact that the particles in volume 26 typicallv acquire an electrostatic charge by contact with the walls of package 22 A high-voltage generator 52 is coupled via contacts 48 and 50 to drive electrodes 44 and 46, respectively, at opposite sides of opening 41, and similarly via contacts 68 and 70 to drive electrodes 74 and 76, respectively, at the sides of opening 43 (Although only a single pair of electrodes is shown at the sides of each opening 41 and 43 it will be understood that multiple electrodes may similarly be used for this purpose ) Preferably, the generator drives the electrodes to produce an alternating electrostatic field in openings 41 and 43 having a peak amplitude of about 3000 volts, at a frequency between 1 and 100 Hz If the dimensions of package 22 and the characteπstics of the field are appropπately chosen, the electrostatic valve screen and the coils on side walls 23 and 25 can be driven at the same frequency, using a common frequency generator in control unit 40. When the electrostatic field is on, charged particles in the vicinity of openings 41 and 43 oscillate and are trapped in the electrostatic field, as long as the air flow velocity through the openings is below a given threshold. The threshold level is a function of the field strength and frequency and may be adjusted by varying one or both of these parameters. Typically, the threshold air flow velocity is set to about 1 liter/min, and the actual flow rate exceeds this velocity only when the patient inhales. Thus, device 20 releases the powder from package 22 in synchronization with the patient's breath cycle, without the need for a flow sensor or active synchronization. Alternatively, mechanical valves, as are known in the art, may be used to close off openings 41 and 43 during times other than the inhalation portion of the patient's breath cycle. Figs. 3 A and 3B are schematic illustrations showing vibration of side walls 23 and 25 when control unit 40 drives the coils thereon, in accordance with preferred embodiments of the present invention. The solid lines show the side walls at one extremum of their vibration, and the dashed lines show the opposite extremum. The amplitude of the vibration (i.e., the distance between the extrema) is exaggerated for clarity of illustration. In the embodiment of Fig. 3 A, all of coils 28, 30, 32 and 34, together with coils 58, 60, 62 and 64, are driven in phase with one another. Therefore, walls 23 and 25 vibrate in phase with one another, thereby deaggregating and suspending powder 66. Since the vibrations are in phase, the total volume containing the powder is largely constant despite the vibrations, so that there are only minimal pressure variations inside package 22, and the powder is unlikely to be pumped out through one of the openings. In the embodiment of Fig. 3B, however, the coils on wall 23 are driven in opposite phase to the coils on wall 25. The vibrations of walls 23 and 25 are similarly oppositely phased, thus creating a pumping action that can be used to aid in expelling powder 66 when desired. Fig. 4A is a schematic illustration showing another mode of vibration of side walls 23 and 25, in accordance with a preferred embodiment of the present invention. In this case, coils 28, 30, 58 and 60 are driven in opposite phase to coils 32, 34, 62 and 64, thus inducing a higher-order vibrational mode of the walls. Other vibrational modes can similarly be induced by appropriately varying the phases and, optionally, amplitudes of the currents used to drive the various coils. Fig. 5 is a schematic illustration showing details of an inhalation device 80, in accordance with another preferred embodiment of the present invention. Device 80 is largely similar to device 20, described hereinabove, except that it uses a different technique to induce vibration of walls 23 and 25. A package 82 is similar in construction to package 22, except that this package has a magnetic coating 84 on the walls. The coating preferably comprises iron (Fe) or a ferrous compound, for example iron cobalt or gamma Fe203, which are widely used in the magnetic recording field. Electromagnets 86 and 88, respectively comprising coils 90 and 92, are placed at either side of package 82. A driver 94 provides an alternating current to the coils, which thus generate a time-varying magnetic field. The field interacts with coating 84 on the side walls, inducing vibration of the walls. There may be multiple adjacent coils on each of electromagnets 86 and 88, like the multiple coils on walls 23 and 25 of package 22. Driver 94 may further control the phase of the currents supplied to the coils so as to vary the spatial distribution of the magnet field and thus affect the vibrational mode of the walls, as described hereinabove. Fig. 6A is a schematic, sectional illustration of a particle of powder 96, in accordance with still another preferred embodiment of the present invention. The particle preferably comprises a magnetic or electrically-active coating 99 applied around a core 98 containing a medication to be administered to a patient. Alternatively, the particle may comprise a magnetic core, to which the medication is applied as a coating. If the coating is of the electrically-active type, it preferably comprises a substance such as sodium, potassium or calcium, which acquires electrical charge with a low work function by contact with a conductive area of the walls of package 22 or with a suitable electrode in the package. The powder can then be more effectively trapped by the electrostatic valve screen, typically at a lower voltage than would otherwise be required. Fig. 6B is a schematic illustration showing details of an inhalation device 100 for use with particles of powder 96 having a magnetic coating 99, in accordance with a preferred embodiment of the present invention. Device 100 and a powder package 102 therein are substantially similar in design and operation to device 80 and package 82 shown in Fig. 5, except that package 102 does not require magnetic coating 84 on its side walls. Instead, coating 99 of the particles of powder 96 interacts with the time-varying magnetic field generated by coils 90 and 92, causing deaggregation and suspension of the particles in volume 26 There is no need for vibration of side walls 23 and 25 for this purpose, as there is in the other embodiments described hereinabove Fig 7 is a schematic, pictorial illustration showing a multi-dose powder dispenser cartridge 120, in accordance with a preferred embodiment of the present invention Cartridge 120 comprises a row of conjoined packets 122 containing a medication in dry powder form, to be dispensed by inhalation using a suitable device having the general form and function of device 20, shown in Fig 1 Each of packets 122 takes the place of package 22 in device 20, and functions in a generally similar manner The packets are inserted in succession, as needed, into the inhaler device, preferably without separating the packets in the row one from another Preferably, cartridge 120 is disposable, and is thrown away after the doses in all of packets 122 have been exhausted, whereas the inhalation device with control and power electronics is reused indefinitely When a dose of the medication is to be administered, one of packets 122 is slid into an operating position inside the inhaler device. Protective strips 134 and 136 are peeled away, uncovering air openings 141 and 143. An alternating electrical current is driven through coils 128 and 158 on upper and lower walls 123 and 125, respectively, of the packet, via contacts 124. (For simplicity of illustration, the contacts for coils 158 are not shown in the figure.) As described hereinabove, the alternating current causes walls 123 and 125 to vibrate, thereby deaggregating the powder Preferably, a transducer 130 serves as a vibration sensor, generating signals responsive to the vibration of wall 123, which signals are received via contacts 132 by a controller of the inhalation device, such as control unit 40 of device 20 The transducer signals are used in controlling the alternating current applied to the coils, most preferably to adjust the frequency of the current so as to maximize the energy of wall vibration, as described further hereinbelow Preferably, transducer 130 comprises a pick-up coil, in which a current flows responsive to movement of the coil in the external magnetic field applied to packet 122, for example, by magnets 36 and 38 Alternatively, transducer 130 may comprise an accelerometer or a microphone, which senses acoustic radiation produced by vibration of the walls of the packet (in which case the transducer may also be positioned adjacent to, rather than on, wall 123). Cartridge 120 is advantageous in that it allows multiple doses to be dispensed in succession, conveniently and reliably. Other cartridge shapes and configurations may similarly be used for this purpose. For example, packets 122 may be arranged in a ring. Figs. 8 and 9 schematically illustrate circuitry and methods used in automatically tracking dosage administered by an inhaler device, in accordance with a preferred embodiment of the present invention. Fig. 8 is a block diagram of circuitry used for this purpose, and Fig. 9 is a flow chart illustrating the tracking method. The circuitry and method are preferably, although not necessarily, used in conjunction with a multi-dose cartridge, such as cartridge 120 shown in Fig. 7. Before the powder dose in one of packets 122 is released, a cell presence detector 160 detects that the packet is properly positioned in a dispensing position in the inhaler device. Detector 160 preferably detects an electrical resistance between contacts 124 or 132 on the packet and, assuming the resistance to be within a predetermined range, notifies control unit 40 of the presence of the packet. Alternatively, detector 160 may detect a short circuit between suitable, dedicated terminals on the packet (not shown in the figures). Further alternatively, detector 160 may sense the position of packet 122 mechanically or optically, using sensing methods known in the art. Once control unit 40 determines that the packet is suitably positioned, it enables the inhaler device to operate. The device is then actuated by means of operational keys 164 and/or by a flow sensor (not shown), so as to apply electrical current to coils 128 and 158. Preferably, electrostatic valve screens are applied at openings 141 and 143, as described hereinabove, to keep the powder in the packet until it is inhaled by the patient. Following actuation, a dose counter 162, typically comprising a memory segment associated with control unit 40, is incremented to record that the medication was administered. Preferably, the time and date of the dose, as provided by a real-time clock 168, are also recorded in the memory. The patient or medical caregiver can then see on a display 166 a record of doses administered, for purposes of avoiding overdosage or underdosage and of tracking patient compliance. After the dose counter has been incremented, control unit 40 waits for detector 160 to indicate that a new packet 122 has been moved into position before allowing the device to be actuated again. Fig. 10 is a block diagram that schematically illustrates circuitry used in controlling the frequency of the electrical current applied to coils 128 and 158, in accordance with a prefeπed embodiment of the present invention The purpose of controlUng the frequency is typically to maximize the vibrational energy of walls 123 and 125 for a given input power to the coils Such maximal energy is generally achieved when the frequency is such that the walls vibrate at a mechanical resonant frequency thereof The resonant frequency may vary from packet to packet or from cartridge to cartridge as a result of differences in the dimensions and materials of the packets For this reason, the circuitry of Fig 10 is useful in adjusting the frequency for each packet It will be understood that such circuitry may be applied, as well, to drive the coils of packet 22, shown in Figs 1 and 2 Control unit 40 receives signals from transducer 130, indicative of the amplitude and frequency of vibration of the wall of packet 122 The signals are processed to determine the energy of vibration of the wall, which is generally maximal when the wall is dπven to vibrate at its mechanical resonant frequency, as noted above The control umt vanes the frequency of an oscillator 170 (which may also be implemented in software running on the control umt itself), which frequency is supplied to a dπver amplifier 172, coupled to coil 128 As the frequency is swept through the resonant frequency of the wall, the control umt detects a corresponding peak m the vibrational energy sensed by sensor 130 and locks onto the peak frequency Fig 11 is a block diagram that schematically illustrates a circuit for use in controlling the frequency of the current applied to coils 128 and 158, in accordance with another preferred embodiment of the present invention In this case, transducer 130 and dπver amplifier 172 are included in a positive feedback loop, coupled by a phase compensation network, as is known in the art The loop tends to oscillate at a resonant frequency that is determined by the resonant vibration frequency of wall 123, since at this frequency the output signal of transducer 130 is typically maximized Thus, maximal vibration of the walls of packet 122 (or, similarly, of packet 22) is achieved without the need for active frequency control by control umt 40 Fig 12 is a schematic, sectional illustration of a powder package 180, in accordance with another preferred embodiment of the present invention The package has the form of a blister pack, for ease of manufacture, formed from an upper layer 182 and a lower layer 184 of a suitable plastic material A blister 186 between the upper and lower layers, having at least one air flow opemng 41, holds powder 66 A pπnted circuit coil 190 is formed on an outer surface of package 180 at one end thereof, which end is positioned between magnets 36 and 38. The other end of the package is held in a holding clip 188. When current flows in coil 190, it causes vibration of the entire package 180, rather than just the walls of blister 186, but the deaggregation effect is substantially similar to that described hereinabove with respect to other preferred embodiments. Fig. 13 is a schematic, sectional illustration of a powder inhaler device 200, in accordance with a preferred embodiment of the present invention. Device 200 comprises a base 201, which contains a source of mechanical energy, in this case a motor 202. The motor is powered by a battery 203 and is actuated by a user-operated switch 204. An air flow guide 211 mates with base 201 at a connection joint 212. Inside guide 211, an oscillating powder container assembly 206 holds a powder which is administered to a patient when the patient places a proximal end 213 of the guide in his or her mouth and inhales. Preferably, container assembly 206 and guide 211 are disposable elements. Assembly 206 is mounted to rotate back and forth about a joint 208. The rotation is induced by contact between an eccentric impactor 205, which is driven by motor 202, and a distal region 210 of the container assembly. Powder for administration to the patient is held in a pocket 207. Motor 202 drives impactor 205 to rotate, so that the impactor contacts region 210 periodically. The motion of the impactor striking the container assembly causes the assembly to oscillate about joint 208 at a resonant frequency that is determined by the mass and other mechanical properties of the assembly. Preferably, assembly 206 includes a flexible portion 209, which enhances the resonant oscillation. Oscillation of assembly 206 deaggregates and mobilizes the powder in pocket 207. Fig. 14 is a schematic end view of impactor 205, in accordance with a preferred embodiment of the present invention. The impactor has an asymmetric protrusion 220, which strikes region 210 as the impactor rotates, thus imparting mechanical energy to assembly 206. Contact between protrusion 220 and region 210 causes assembly 206 to rotate about joint 208 in a counterclockwise direction (in the view of Fig. 13), so that region 210 moves away from impactor 205. The force of gravity then causes assembly 206 to rotate back clockwise, at the resonant oscillatory frequency of the assembly, so that region 210 again contacts the impactor and is struck by protrusion 220. Preferably, the force of counter-rotation is enhanced by mechanical deformation of assembly 206 (particularly of portion 209 of the assembly). Alternatively or additionally, device 200 may be configured so that other forces contribute to the counter-rotation of assembly 206, including air pressure changes within guide 211, as described below. Typically, the resonant frequency of assembly 206 is in the range of 50 to 500 Hz. Impactor 205 preferably moves at a frequency between 100 Hz and 20 kHz. (Although the higher speeds in this range may not be practical using a rotating impactor driven by a miniature motor, as shown in Figs. 13 and 14, these high speeds can be attained using impactors of other types, such as electromagnetic or piezoelectric oscillating elements.) The frequency of motion of impactor 205 is preferably chosen to be substantially greater than the resonant frequency of assembly 206. As a result, every time region 210 moves in toward the impactor, the impactor strikes and imparts energy to the region. Because the energy source (the impactor) and the assembly are coupled to one another only intermittently, at one extreme of the oscillatory range of the assembly, rather than being continuously coupled, there is no need to match the frequency of the energy source to the resonant frequency of the assembly. This intermittent coupling scheme will also work when the frequency of motion of impactor 205 is less than the resonant frequency of assembly 206, except that in this case, protrusion 220 will not contact region 210 on every oscillation of the assembly. Additionally or alternatively, motor 202 and impactor 205 may be arranged so as to cause vibration of device 200 as a whole, thereby deaggregating the powder in the container assembly. Such vibration may be induced, for example, by an intentional imbalance of the impactor. Returning now to Fig. 13, it will be observed that when the patient inhales through proximal end 213 of guide 211, air flows into the guide through an inlet 214. The air flows over pocket 207 so as to carry the powder into the patient's mouth. Preferably, the inlet is positioned and configured so that the air flow also exerts pressure on assembly 206, driving region 210 against impactor 205 with increased force. As a result the container assembly oscillates with increased amplitude while the patient inhales. Preferably, device 200 is designed so that while the air inside guide 21 1 is still, assembly 206 oscillates at a relatively low amplitude, which is only sufficient to deaggregate the powder in the container assembly. When the patient inhales, the air flow causes the amplitude of oscillation to increase, so that the powder is aerosolized. Stronger inhalation induces still stronger oscillation, and thus increases the amount of powder that is mobilized and delivered to the patient. The variation of oscillation strength between the deaggregation and aerosohzation levels is naturally synchronized with the patient's breathing In another preferred embodiment of the present invention, the inherent oscillation of the container assembly (before the patient inhales) is sufficient to aerosolize the powder, but the powder remains sealed within the device until the patient actually inhales Preferably, an electrostatic valve screen is used for this purpose, as described above Alternatively, a mechamcal seal can be used to retain the powder inside the device The patient's inhalation provides the force needed to overcome the seal or, alternatively, triggers another mechamsm that releases the seal It will be appreciated that the preferred embodiments descπbed above are cited by way of example, and the principles of the present invention may similarly be embodied in different configurations and combinations of the elements and concepts shown and described herein The full scope of the invention is thus limited only by the claims

Claims: CLAIMS 1 An inhaler device for administration of a dry powder to a patient, comprising a package contaimng a dose of the dry powder, and a magnetic field generator, which produces a magnetic field in a vicimty of the package, causing motion of particles of the powder so as to deaggregate the powder in the package, whereby the powder is inhaled by the patient 2 A device according to claim 1, wherein the package compπses walls made of a flexible material, which vibrate under the influence of the magnetic field so as to impart the motion to the particles 3 A device according to claim 2, and compπsing electπcal wiring coupled to at least one of the walls and a control umt which drives a time-varying current through the wiπng, causing the walls to vibrate due to interaction of the current with the magnetic field 4 A device according to claim 3, wherein the wiring compπses a circuit trace printed on at least one of the walls 5 A device according to claim 3, wherein the wiring comprises a plurality of coils 6 A device according to claim 5, wherein the control unit drives the plurality of coils at respective relative phases so as to induce a desired mode of vibration of the at least one of the walls 7 A device according to claim 2, wherein the walls compπse a magnetic mateπal, and wherein the field generator comprises an electromagnet, which produces a time-varying magnetic field, causing the walls to vibrate due to interaction of the magnetic mateπal with the magnetic field 8 A device according to claim 7, wherein the magnetic mateπa! comprises a coating on the one or more of the walls 9 A device according to claim 2, wherein the walls made of the flexible material comprise opposing side walls of the package, which vibrate in a controlled mutual phase relationship 10 A device according to claim 9, wherein the opposing side walls are driven to vibrate in phase 1 1 A device according to claim 9, wherein the opposing side walls are driven to vibrate in mutually opposite phases so as to pump the powder out of the package 12 A device according to claim 2, wherein the walls are driven to vibrate at a frequency approximately equal to a resonant vibration frequency thereof 13 A device according to claim 12, and comprising a driver circuit, which provides an alternating current of adjustable frequency to drive the vibration of the walls, and a vibration transducer coupled to one of the walls, which transducer provides feedback to the driver circuit, so that the frequency of the alternating current is adjusted such that the walls vibrate at approximately the resonant vibration frequency 14 A device according to claim 13, wherein the driver circuit and transducer are arranged in a self-oscillating positive feedback loop 15 A device according to claim 2, and comprising a vibration sensor, which generates signals responsive to vibration of the walls, and a control unit, which receives the signals from the vibration sensor and, responsive thereto, controls the inhaler device so as to regulate an energy of vibration of the walls 16. A device according to claim 15, wherein the control unit provides an alternating current of adjustable frequency to drive the vibration of the walls, and wherein the control unit adjusts the frequency of the alternating current in order to maximize the energy of vibration 17 A device according to any of the preceding claims, wherein the powder comprises magnetized particles, and wherein the field generator produces a time-varying magnetic field which interacts with magnetic fields of the particles, causing the particles to move 18 A device according to claim 17, wherein a frequency of the time-varying magnetic field is adjusted so that the particles oscillate at approximately a resonant frequency thereof 19 A device according to any of claims 1-16, wherein the package comprises a multi-dose cartridge, such that multiple doses of the dry powder are administered to the patient in succession, and comprising a dose counter which tracks the administration of the doses 20. A device according to any of claims 1-16, and comprising an electrostatic valve screen, which traps the powder inside the package by generating a time-varying electrostatic field across an opening of the package. 21. .An inhaler device for administration of a dry powder to a patient, comprising: a package containing a dose of the dry powder and having an opening through which the powder exits the package and is inhaled by the patient; and an electrostatic valve screen, which traps the powder inside the package by generating a time-varying electrostatic field across the opening. 22. A device according to claim 21 , wherein the valve screen comprises a pair of electrodes positioned on opposing sides of the opening. 23. A device according to claim 21. wherein the electrostatic valve screen allows the powder to pass through the opening when a rate of air flow through the opening exceeds a predetermined threshold. 24. A device according to claim 23, wherein the threshold is chosen such that inhalation by the patient generates an air flow through the opening in excess of the threshold. 25. A device according to any of claims 21-24, wherein the electrostatic field causes particles of the powder to oscillate in a vicinity of the opening. 26. A method for deaggregation of a dry powder for administration to a patient, comprising applying a magnetic field so as to cause motion of panicles of the powder, whereby the powder is inhaled by the patient. 27. A method according to claim 26. wherein the powder is contained in a package having walls made of a flexible material, and wherein applying the magnetic field comprises magnetically inducing vibration of the walls so as to impart the motion to the particles. 28. A method according to claim 27. wherein inducing the vibration compπses driving a time-varying current in wiring coupled to at least one of the walls, which current interacts with the magnetic field to induce the vibration of the walls. 29. A method according to claim 28, wherein driving the current comprises driving current in different portions of the wiring at respective, relative phases so as to induce a desired mode of vibration of the walls. 11 30 A method according to claim 27, wherein inducing the vibration comprises applying a time-varying magnetic field, which interacts with magnetic material in the walls to induce the vibration 31 A method according to claim 27. wherein inducing the vibration compπses controlling relative phases of vibration of different ones of the walls 32 A method according to claim 2 " wherein inducing the vibration compπses dπving the vibration at approximateh a resonant \ ιbratιon frequency of the walls 33 A method according to claim 2", wherein inducing the vibration compπses sensing vibration of one of the walls and adjusting a frequency of the vibration responsive to the sensing 34 A method according to any of claims 27-33, and comprising magnetizing the panicles, wherein applying the magnetic field compπses applying a time-varying magnetic field which interacts with magnetic fields of the panicles, causing the panicles to move 35 A method according to any of claims 27-33, and comprising generating a time-varying electrostatic field so as to trap the powder until it is inhaled by the patient 36. A method for administration of a dry powder to a patient, comprising: providing the dry powder in a package having an opening through which the powder exits the package and is inhaled by the patient, and generating a time-varying electrostatic field across the opemng so as to trap the powder inside the package until the patient inhales 37 A method according to claim 36. wherein generating the field compπses adjusting the strength of the field so as to allow the powder to pass through the opening only when a rate of air flow through the opemng exceeds a predetermined threshold 38 A method according to claim 37 wherein the threshold is chosen such that inhalation by the patient generates an air flow through the opemng in excess of the threshold 39 A method according to any of claims 36-38, wherein generating the electrostatic field causes particles of the powder to oscillate in a vicinity of the opening 40 An inhaler device for administration of a dry powder to a patient, comprising. a container assembly, containing a dose of the dry powder and adapted to oscillate over a predetermined oscillation path between first and second extremes, and an impactor, configured to dπve the container assembly to oscdlate by contacting the container assembly peπodically in a vicimty of the first extreme of the oscillation path, but not in a vicimty of the second extreme, so as to deaggregate the dry powder for inhalation by the patient 41 A device according to claim 40, wherein the container assembly is adapted to oscillate at a resonant frequency of the assembly, so that the impactor contacts the container periodically at the resonant frequency 42 A device according to claim 41, and compπsmg an energy source, which is coupled to dπve the impactor into motion at a frequency substantially greater than the resonant frequency, wherein the motion of the impactor causes it to contact the container assembly 43 A device according to any of claims 40-42, wherein the impactor compπses an eccentric rotating element 44 A device according to any of claims 40-42, wherein the container assembly is configured so that responsive to a flow of air over the assembly, an amplitude of oscillation of the assembly increases 45 A device according to claim 44, wherein the flow of air is induced by the patient's inhalation 46 A device according to any of claims 40-42, and comprising a housing enclosing the container assembly, the housing compπsing a sealing mechanism, which is adapted to trap the powder inside the housing and to open so as to allow the powder to pass through an opemng in the housing responsive to inhalation by the patient 47 A device according to claim 46, wherein the sealing mechanism compπses an electrostatic valve screen, which traps the powder inside the package by generating a time-varying electrostatic field across the opemng 48 An inhaler device for administration of a dry powder to a patient, compπsing a housing, containing the powder and having an outlet adapted for the patient to inhale the powder therethrough and an inlet through which air is drawn into the housing when the patient inhales, and a deaggregation assembly inside the housing, which is adapted to apply a vibration to the powder so as to deaggregate the powder for inhalation by the patient, such that an amplitude of the vibration is increased when the patient inhales. 49. A device according to claim 48, wherein the amplitude of the vibration is increased responsive to the air flowing through the housing when the patient inhales. 50. A device according to claim 49, wherein the air flowing through the housing applies a force to the deaggregation assembly, causing the amplitude of the vibration to increase. 51. A device according to any of claims 48-50, wherein before the patient inhales, the amplitude of the vibration of the deaggregation assembly is not sufficient to mobilize the powder substantially, so that the powder remains inside the housing, whereas when the patient inhales, the amplitude of the vibration is increased sufficiently to aerosolize the powder. 52. A device according to any of claims 48-50, wherein the amplitude of the vibration of the deaggregation assembly is increased to a greater degree in response to a greater strength of inhalation by e patient. 53. A device according to any of claims 48-50, wherein the housing comprises a sealing mechanism, which is adapted to trap the powder inside the housing and to open so as to allow the powder to pass through the opening responsive to inhalation by the patient. 54. A device according to claim 53, wherein the sealing mechanism comprises an electrostatic valve screen, which traps the powder inside the package by generating a time-varying electrostatic field across the opening. 55. A method for administration of a dry powder to a patient, comprising: providing a dose of the dry powder in a container assembly, which is adapted to oscillate over a predetermined oscillation path between first and second extremes; and driving the container assembly to oscillate by striking the container assembly periodically in a vicinity of the first extreme of the oscillation path, but not in a vicinity of the second extreme, so as to deaggregate the dry powder for inhalation by the patient 56. A method according to claim 55, wherein driving the container assembly to oscillate comprises driving the assembly to oscillate at a resonant frequency thereof. 57. A method according to claim 55 or 56, wherein driving the container assembly to oscillate comprises increasing an amphtude of oscillation of the assembly responsive to a flow of air over the assembly. 58. A method according to claim 57, wherein the flow of air is induced by the patient's inhalation. 59. A method for administration of a dry powder to a patient by inhalation, comprising: applying a vibration to the powder at an initial vibration amplitude so as to deaggregate the powder prior to the inhalation by the patient; and increasing the amplitude of the vibration during the inhalation by the patient so as to aerosolize the powder. 60. A method according to claim 59, wherein increasing the amplitude of the vibration comprises increasing the amplitude responsive to air flowing through a housing containing the powder due to the inhalation by the patient. 61. A method according to claim 60, wherein the air flowing through the r using applies a force to a vibrating assembly in the r ousing, causing the amplitude of the vibration to increase. 62. A method according to claim 60 or 61, wherein the housing has a sealing mechanism which traps the powder inside the housing, and comprising opening the sealing mechanism to release the powder responsive to the air flowing through the housing. 63. An inhaler device for administration of a dry powder to a patient, comprising. a package containing a dose of the dry powder and having an opening through which the powder exits the package and is inhaled by the patient; and a sealing mechanism, which is operative to trap the powder inside the package and to open so as to allow the powder to pass through the opening responsive to inhalation by the patient. 64. A device according to claim 63, wherein the sealing mechanism is operative to open responsive to air flow generated due to the inhalation. 65. A device according to claim 64, wherein the sealing mechanism is adapted to allow the powder to pass through the opening only when a rate of the air flow through the opening exceeds a predetermined threshold. 66 A method for administration of a dry powder to a patient, comprising' providing the dry powder in a package having an opening; applying a sealing mechanism to the opening so as to trap the powder inside the package, and releasing the sealing mechanism so as to allow the powder to pass through the opening for inhalation by the patient only when a rate of air flow through the opening exceeds a predetermined threshold 67 A method according to claim 66, wherein the threshold is chosen such that inhalation by the patient generates an air flow through the opening in excess of the threshold

Inventors: AVRAHAMI ZOHAR, SOHN ZEEV, AVRAHAMI, ZOHAR, SOHN, ZEEV
Applicants: AVRAHAMI ZOHAR, SOHN ZEEV, TRANSPHARMA LTD, AVRAHAMI, ZOHAR, SOHN, ZEEV, TRANSPHARMA LTD.
Application year: 2000
Main classification: A61M
IPC codes: A61M15